Author
Listed:
- Santos A. Susin
(Centre National de la Recherche Scientifique, UPR 420)
- Hans K. Lorenzo
(Unit de Biochimie Structurale, Institut Pasteur)
- Naoufal Zamzami
(Centre National de la Recherche Scientifique, UPR 420)
- Isabel Marzo
(Centre National de la Recherche Scientifique, UPR 420)
- Bryan E. Snow
(The Amgen Institute and Ontario Cancer Institute, University of Toronto)
- Greg M. Brothers
(The Amgen Institute and Ontario Cancer Institute, University of Toronto)
- Joan Mangion
(The Amgen Institute and Ontario Cancer Institute, University of Toronto)
- Etienne Jacotot
(Centre National de la Recherche Scientifique, UPR 420)
- Paola Costantini
(Centre National de la Recherche Scientifique, UPR 420)
- Markus Loeffler
(Centre National de la Recherche Scientifique, UPR 420)
- Nathanael Larochette
(Centre National de la Recherche Scientifique, UPR 420)
- David R. Goodlett
(University of Washington)
- Ruedi Aebersold
(University of Washington)
- David P. Siderovski
(The Amgen Institute and Ontario Cancer Institute, University of Toronto)
- Josef M. Penninger
(The Amgen Institute and Ontario Cancer Institute, University of Toronto)
- Guido Kroemer
(Centre National de la Recherche Scientifique, UPR 420)
Abstract
Mitochondria play a key part in the regulation of apoptosis (cell death)1,2. Their intermembrane space contains several proteins that are liberated through the outer membrane in order to participate in the degradation phase of apoptosis3,4,5,6,7,8,9. Here we report the identification and cloning of an apoptosis-inducing factor, AIF5, which is sufficient to induce apoptosis of isolated nuclei. AIF is a flavoprotein of relative molecular mass 57,000 which shares homology with the bacterial oxidoreductases; it is normally confined to mitochondria but translocates to the nucleus when apoptosis is induced. Recombinant AIF causes chromatin condensation in isolated nuclei and large-scale fragmentation of DNA. It induces purified mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Microinjection of AIF into the cytoplasm of intact cells induces condensation of chromatin, dissipation of the mitochondrial transmembrane potential, and exposure of phosphatidylserine in the plasma membrane. None of these effects is prevented by the wide-ranging caspase inhibitor known as Z-VAD.fmk. Overexpression of Bcl-2, which controls the opening of mitochondrial permeability transition pores, prevents the release of AIF from the mitochondrion but does not affect its apoptogenic activity. These results indicate that AIF is a mitochondrial effector of apoptotic cell death.
Suggested Citation
Santos A. Susin & Hans K. Lorenzo & Naoufal Zamzami & Isabel Marzo & Bryan E. Snow & Greg M. Brothers & Joan Mangion & Etienne Jacotot & Paola Costantini & Markus Loeffler & Nathanael Larochette & Dav, 1999.
"Molecular characterization of mitochondrial apoptosis-inducing factor,"
Nature, Nature, vol. 397(6718), pages 441-446, February.
Handle:
RePEc:nat:nature:v:397:y:1999:i:6718:d:10.1038_17135
DOI: 10.1038/17135
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Wenjun Wang & Junyang Tan & Xiaomin Liu & Wenqi Guo & Mengmeng Li & Xinjie Liu & Yanyan Liu & Wenyu Dai & Liubing Hu & Yimin Wang & Qiuxia Lu & Wen Xing Lee & Hong-Wen Tang & Qinghua Zhou, 2023.
"Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress,"
Nature Communications, Nature, vol. 14(1), pages 1-16, December.
- Malgorzata Orylska-Ratynska & Waldemar Placek & Agnieszka Owczarczyk-Saczonek, 2022.
"Tetracyclines—An Important Therapeutic Tool for Dermatologists,"
IJERPH, MDPI, vol. 19(12), pages 1-13, June.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:397:y:1999:i:6718:d:10.1038_17135. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.